NASD · Healthcare · Biotechnology · Israel
Compugen Ltd is a micro cap company (market value under $300 million) in the Biotechnology industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the Compugen Ltd stock.
Undervalued: intrinsic value $8.65 per share, market price $1.98, margin of safety 77.1% (as of 2026-10-30).
Discounting its cash flows at 16.3% (average of 3 methods) values the shares at $8.65; the price of $1.98 is 77% below that value, and 58% of that value comes from beyond year five.
Leak Score: 85/100 on 10 of 12 signals (Strong Leak).
CGEN is undervalued (as of the 2026-10-30 close). Discounting its cash flows at 16.3% (average of 3 methods) values the shares at $8.65; the price of $1.98 is 77% below that value, and 58% of that value comes from beyond year five.
$8.65 per share (as of the 2026-10-30 close), against a market price of $1.98. That is a margin of safety of 77.1%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
85 out of 100, which we rate "Strong Leak", on 10 of 12 value investing signals.